✦ LIBER ✦

High-dose chemotherapy (HDC) with autologous progenitor cell support (APCS) for breast cancer patients with high risk stage II–III, and stage IV with no evidence of disease (NED)

✍ Scribed by Stemmer, S.M.; Jones, R.B.; Shpall, E.J.; Bearman, S.I.; Myers, S.E.; Taffs, S.; McDermitt, J.

Book ID: 122084599
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 128 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)90989-S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility and low toxicity of early ra

Feasibility and low toxicity of early radiotherapy after high-dose chemotherapy and autologous stem cell transplantation for patients with high-risk Stage II–III and locally advanced breast carcinoma

✍ Salomon M. Stemmer; M. Raphael Pfeffer; Shulamith Rizel; Izhar Hardan; Jana Goff 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Adjuvant treatment of high-risk stage II

Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients

✍ Stemmer, S M; Hardan, I; Raz, H; Adamou, A K; Inbar, M; Gottfried, M; Merrick, Y 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 144 KB

High-dose chemotherapy and stem cell tra

High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome

✍ Ahmed, T; Kancherla, R; Qureshi, Z; Mittelman, A; Seiter, K; Mannancheril, A; Pu 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

Quality of life among patients with Stag

Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy : Results from Cancer and Leukemia Group B 9066

✍ Jeffrey Peppercorn; James Herndon II; Alice B. Kornblith; William Peters; Tim Ah 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to compare the quality of life (QOL) after treatment among patients who had breast carcinoma with multiple positive lymph nodes. The patients were randomized to receive either high‐dose chemotherapy with autologous stem cell support (HDC) o